Simplex Trading’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,120
Closed -$62K 11039
2022
Q3
$62K Buy
+4,120
New +$47.9K ﹤0.01% 6151
2022
Q2
Sell
-1,512
Closed -$10.7K 11597
2022
Q1
$13K Sell
1,512
-1,015
-40% -$7.82K ﹤0.01% 8705
2021
Q4
$17K Buy
2,527
+1,771
+234% +$18.5K ﹤0.01% 8581
2021
Q3
$12K Buy
756
+100
+15% +$1.46K ﹤0.01% 8851
2021
Q2
$10K Sell
656
-226
-26% -$3.88K ﹤0.01% 9131
2021
Q1
$15K Buy
+882
New +$15.2K ﹤0.01% 7691
2020
Q4
Sell
-7,864
Closed -$95K 9335
2020
Q3
$92K Buy
7,864
+7,056
+873% +$85.9K ﹤0.01% 5006
2020
Q2
$11K Sell
808
-3,708
-82% -$54.9K ﹤0.01% 6626
2020
Q1
$60K Buy
+4,516
New +$85.7K ﹤0.01% 4955
2019
Q4
Sell
-12,009
Closed -$249K 8221
2019
Q3
$230K Sell
12,009
-14,604
-55% -$335K ﹤0.01% 3418
2019
Q2
$786K Buy
26,613
+2,218
+9% +$85.5K ﹤0.01% 2135
2019
Q1
$1.16M Buy
24,395
+13,186
+118% +$580K ﹤0.01% 1862
2018
Q4
$404K Sell
11,209
-10,344
-48% -$485K ﹤0.01% 2432
2018
Q3
$1.33M Buy
21,553
+13,857
+180% +$891K ﹤0.01% 1600
2018
Q2
$519K Buy
7,696
+5,924
+334% +$331K ﹤0.01% 2426
2018
Q1
$96K Buy
+1,772
New +$99.1K ﹤0.01% 1842
2017
Q3
Sell
-1,341
Closed -$73.2K 6882
2017
Q2
$70K Sell
1,341
-7,125
-84% -$332K ﹤0.01% 2068
2017
Q1
$383K Buy
8,466
+1,169
+16% +$52.1K 0.02% 828
2016
Q4
$276K Sell
7,297
-12,691
-63% -$480K 0.02% 852
2016
Q3
$754K Buy
19,988
+19,477
+3,812% +$430K 0.05% 348
2016
Q2
$8K Buy
+511
New +$8.27K ﹤0.01% 3857
2015
Q4
Sell
-11,240
Closed -$262K 6362
2015
Q3
$199K Sell
11,240
-59,184
-84% -$1.07M 0.01% 924
2015
Q2
$1.24M Buy
+70,424
New +$1.29M 0.1% 171

Simplex Trading's AERI Position: Q4 2022 in Review

Simplex Trading sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 4,120 shares — an estimated $62K sold.

Simplex Trading first reported a position in AERI in Q2 2015 and held it in 23 quarters. The position peaked at $1.33M in Q3 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Simplex Trading reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 4,120 Aerie Pharmaceuticals shares in Q4 2022, an estimated $62K.
  • Simplex Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 23 quarters.
  • Simplex Trading's Aerie Pharmaceuticals position peaked at $1.33M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.